Latest Regulatory Approvals News

Power Minerals Limited updates its acquisition of the Gamma Heavy Rare Earths Project in California, clarifying historical data limitations and securing $4.1 million to fund exploration activities.

Optiscan Imaging has entered a three-year strategic collaboration with Australian Clinical Labs to validate and deploy its InForm™ digital pathology platform, aiming to transform diagnostic workflows with real-time tissue analysis.

AGL Energy has agreed to divest 19.9% of its 20% stake in Tilt Renewables for $750 million, reinforcing its strategy to recycle capital and invest in flexible energy capacity while maintaining a strategic partnership.

Memphasys Limited has successfully raised over $1.1 million through a pro-rata entitlement offer to accelerate the commercialisation of its innovative Felix™ sperm selection system, targeting key regulatory approvals and market expansion.

New Frontier Minerals has secured regulatory approval to launch its first reverse circulation drilling campaign at the Harts Range Heavy Rare Earth and Niobium Project, while also preparing for a US OTCQB listing to broaden investor reach.

Mandrake Resources has signed a term sheet with DISA Technologies to explore recovering uranium and critical minerals from abandoned mine waste in Utah, leveraging a unique US regulatory license and strong government backing.

NexGen Energy Ltd. reported a significant net loss for the nine months ended September 30, 2025, driven by mark-to-market losses on convertible debentures and impairment charges. The company bolstered its liquidity with a $953 million equity raise post-period.

Jade Gas Holdings has signed a non-binding Letter of Intent with Chinese partner Langrun for up to A$70 million in non-dilutive financing to fast-track its Red Lake LNG project in Mongolia. This deal could significantly advance drilling, production, and gas processing operations.

AUB Group has approved EQT's partnership with CVC Asia Pacific to jointly pursue a $45 per share acquisition, extending exclusivity to December 4 as due diligence continues.

Lunnon Metals has secured shareholder approval for its Ore Purchase Agreement and chosen Hampton Mining as the preferred contractor for its Lady Herial gold open pit, moving closer to operational commencement pending regulatory permits.

Invex Therapeutics Ltd has been suspended from trading on the ASX due to a failure to maintain the minimum number of directors required by law. The suspension will remain until the company rectifies its governance structure and complies with listing rules.

Mayne Pharma’s acquisition by Cosette Pharmaceuticals faces a regulatory delay as the Foreign Investment Review Board extends its approval deadline, pushing the court hearing to mid-November.